Yusuke Honzawa
Overview
Explore the profile of Yusuke Honzawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Dec;
60(2):263-264.
PMID: 39729094
No abstract available.
2.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Nov;
60(1):86-95.
PMID: 39607498
Background: A serum biomarker for diagnosing ulcerative colitis (UC) remains to be established. Although we recently reported an anti-integrin αvβ6 antibody (V6 Ab) for diagnosing UC with high sensitivity and...
3.
Sano Y, Tomiyama T, Yagi N, Ito Y, Honzawa Y, Tahara T, et al.
Sci Rep
. 2024 Nov;
14(1):28055.
PMID: 39543171
Ulcerative colitis (UC) is a refractory, chronic inflammatory bowel disease of unknown etiology. Although platelets are activated in UC, their relevance in pathophysiology remains unclear. We analyzed the correlation of...
4.
Nakamura N, Honzawa Y, Ito Y, Sano Y, Yagi N, Kobayashi S, et al.
Intest Res
. 2024 Aug;
PMID: 39155217
Background/aims: Serum leucine-rich alpha-2 glycoprotein (LRG) is a potential biomarker of Crohn's disease (CD). This study aimed to evaluate the usefulness of LRG in predicting clinical relapse in patients in...
5.
Tahara T, Shijimaya T, Yamazaki J, Kobayashi S, Horitani A, Matsumoto Y, et al.
Cancer Invest
. 2024 Jun;
42(6):469-477.
PMID: 38913915
We examined () and whole () in non-neoplastic Barrett's esophagus (BE) from patients without cancer ( = 67; N group), with esophageal adenocarcinoma (EAC) ( = 27) and EAC tissue...
6.
Nakamura N, Honzawa Y, Ohtsu T, Sano Y, Ito Y, Fukata N, et al.
Clin J Gastroenterol
. 2024 Apr;
17(4):654-657.
PMID: 38683411
Janus kinase (JAK) inhibitors have been developed and are clinically available for management of active UC patients although most studies have been conducted for the outpatients and few studies have...
7.
Tahara T, Shijimaya T, Nishimon S, Kobayashi S, Matsumoto Y, Nakamura N, et al.
J Gastrointestin Liver Dis
. 2024 Feb;
33(1):25-29.
PMID: 38386890
Background And Aims: Non-cardiac chest pain (NCCP) is a frequent complication of endoscopic submucosal dissection (ESD) for early-stage esophageal cancer. However, little is known about relationships between ESD findings and...
8.
Kiyohara H, Yamazaki H, Moriya K, Akimoto N, Kawai S, Takenaka K, et al.
Inflamm Intest Dis
. 2024 Feb;
9(1):1-10.
PMID: 38298887
Introduction: Whether white blood cell (WBC) counts are predictors for the effectiveness of thiopurine treatment in ulcerative colitis (UC) has been inconclusive in previous studies with small sample sizes. We...
9.
Yamada S, Honzawa Y, Yamamoto S, Matsuura M, Kitamoto H, Okabe M, et al.
Inflamm Bowel Dis
. 2023 Nov;
30(6):970-980.
PMID: 37951297
Background: Single nucleotide polymorphisms (SNPs) of the MEFV gene may modify inflammatory bowel disease (IBD) activity. The prevalence of MEFV gene SNPs in IBD patients and their involvement in IBD...
10.
Shijimaya T, Tahara T, Yamazaki J, Kobayashi S, Horitani A, Matsumoto Y, et al.
Epigenomics
. 2023 Sep;
15(15):759-767.
PMID: 37661863
DNA methylation is involved in esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE). Microarchitectures of on-neoplastic BE associated with DNA methylation status were examined using magnifying narrow-band imaging (NBI) endoscopy. Using...